FindTrial
Sign In

Analysis of the clinical application of pregabalin capsules: a multicenter, retrospective real-world study

Analysis of the clinical application of pregabalin capsules: a multicenter, retrospective real-world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061557
Enrollment
Unknown
Registered
2022-06-29
Start date
2022-06-20
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Case series:None

Sponsors

Foshan Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. From May 1, 2016 to May 1, 2021, patients who were prescribed pregabalin capsules with or without follow-up records; 2. Gender and age were not limited.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Changes in patient's condition before and after taking pregabalin capsules;Changes in test results of patients before and after taking pregabalin capsules;The disease distribution characteristics of patients taking pregabalin capsules;The population characteristics of patients taking pregabalin capsules;Clinical application characteristics of pregabalin capsules (including dose, frequency, course of treatment, combined treatment plan);Adverse events/Adverse drug reactions;—

Countries

China

Contacts

Public ContactGuan Jintu

Foshan Hospital of Traditional Chinese Medicine

1479861515@qq.com+86 0757-83068421

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026